Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer

被引：0
|
作者：
Nagano, Tatsuya [1 ]
Tachihara, Motoko [1 ]
Tanaka, Yugo [2 ]
机构：
[1] Kobe Univ, Dept Internal Med, Div Resp Med, Grad Sch Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Div Thorac Surg, Grad Sch Med, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 04期
关键词：
OSIMERTINIB;
D O I：
10.21037/jtd-22-57
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：809 / 811
页数：3
相关论文
共 50 条
  • [41] Are TKIs favourable for the elderly with non-small-cell lung cancer?
    Rossi, Sabrina
    D'Argento, Ettore
    Schinzari, Giovanni
    Dadduzio, Vincenzo
    Di Noia, Vincenzo
    Cassano, Alessandra
    Barone, Carlo
    ONCOTARGET, 2016, 7 (30) : 46871 - 46877
  • [42] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
  • [43] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Zhixin Sheng
    Yanxia Zhang
    Medical Oncology, 2015, 32
  • [44] A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer
    Cheng, Hua
    Li, Xiao-Jian
    Wang, Xiao-Jin
    Chen, Zuo-Wen
    Wang, Rui-Qi
    Zhong, Hong-Cheng
    Wu, Tian-Chi
    Cao, Qing-Dong
    LUNG CANCER, 2019, 137 : 7 - 13
  • [45] Feasibility Study of Sequentially Alternating EGFR-TKIs and Chemotherapy for Patients with Non-small Cell Lung Cancer
    Takemura, Yoshizumi
    Chihara, Yusuke
    Morimoto, Yoshie
    Tanimura, Keiko
    Imabayashi, Tatsuya
    Seko, Yurie
    Kaneko, Yoshiko
    Date, Koji
    Ueda, Mikio
    Arimoto, Taichiro
    Iwasaki, Yoshinobu
    Takayama, Koichi
    ANTICANCER RESEARCH, 2018, 38 (04) : 2385 - 2390
  • [46] Concurrent Combination of EGFR-TKIs and Thoracic Radiation Therapy for Metastatic Non Small Cell Lung Cancer Patients
    Yoshida, M.
    Fujii, T.
    Shida, K.
    Osumi, C.
    Fujii, T.
    Kawata, A.
    Kishigami, T.
    Nishimoto, Y.
    Hasegawa, M.
    Kikuchi, M.
    Gomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S186 - S186
  • [47] Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs
    Umekawa K.
    Kimura T.
    Kudoh S.
    Suzumura T.
    Oka T.
    Nagata M.
    Mitsuoka S.
    Matsuura K.
    Nakai T.
    Yoshimura N.
    Kira Y.
    Hirata K.
    BMC Research Notes, 6 (1)
  • [48] Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
    Shi, Xiaoshun
    Dong, Xiaoying
    Zhai, Jianxue
    Liu, Xiguang
    Lu, Di
    Ni, Zhen
    Wu, Hua
    Cai, Kaican
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    Kubo, Naoki
    Harada, Taishi
    Shiraishi, Yoshimasa
    Nosaki, Kaname
    Nakagaki, Noriaki
    Takeshita, Masafumi
    Ouchi, Hiroshi
    Iwama, Eiji
    Tanaka, Kentaro
    Okamoto, Isamu
    Sasaki, Hiroyuki
    Nakanishi, Yoichi
    ANTICANCER RESEARCH, 2019, 39 (02) : 671 - 677
  • [50] Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
    Tone, Mari
    Iwahori, Kota
    Shiroyama, Takayuki
    Futami, Shinji
    Naito, Yujiro
    Fukushima, Kiyoharu
    Miyake, Kotaro
    Koyama, Shohei
    Hirata, Haruhiko
    Nagatomo, Izumi
    Wada, Hisashi
    Takeda, Yoshito
    Kumanogoh, Atsushi
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345